spinoffs

3 medtech spinoffs that reshaped the industry in 2023, and what to expect next
3 medtech spinoffs that reshaped the industry in 2023, and what to expect next
Medtech Dive
Medtech
spinoffs
GE Healthcare
JNJ
Danaher
Baxter
3M
Medtronic
Flag link:
Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience
Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience
BioSpace
Alkermes
spinoffs
oncology
Mural Oncology
NASDAQ
Flag link:
WuXi Biologics bioconjugates spinout plans $470 million IPO
WuXi Biologics bioconjugates spinout plans $470 million IPO
Biopharma Reporter
WuXi Biologics
IPOs
spinoffs
WuXi XDC
CRDMOs
Flag link:
Sanofi loses $21 bln in market value after dropping 2025 profit target
Sanofi loses $21 bln in market value after dropping 2025 profit target
Reuters
Sanofi
earnings
spinoffs
consumer health
Flag link:
Novartis expats detail their health-tech spinoff DatosX
Novartis expats detail their health-tech spinoff DatosX
Medical Marketing and Media
Novartis
innovation
digital health
spinoffs
DatosX
Flag link:
5 financial challenges facing the medtech sector
5 financial challenges facing the medtech sector
Medtech Dive
Medtech
revenue
M&A
spinoffs
funding
IPOs
Flag link:
J&J could reach market-leading medtech growth after consumer spinoff: analysts
J&J could reach market-leading medtech growth after consumer spinoff: analysts
Medtech Dive
JNJ
Medtech
spinoffs
Kenvue
Flag link:
Sanofi spin-off EuroAPI slumps as revenues falter
Sanofi spin-off EuroAPI slumps as revenues falter
Pharmaphorum
Sanofi
EuroAPI
spinoffs
API
Flag link:
Novartis' Sandoz dips on debut after lower than expected valuation
Novartis' Sandoz dips on debut after lower than expected valuation
Reuters
Novartis
Sandoz
spinoffs
Flag link:
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
Motley Fool
JNJ
Kenvue
consumer health
spinoffs
dividends
Flag link:
Novartis confirms Sandoz spin-off for October 4, 2023
Novartis confirms Sandoz spin-off for October 4, 2023
Reuters
Novartis
Sandoz
spinoffs
Flag link:
Novartis updates on Sandoz finances ahead of spin-off
Novartis updates on Sandoz finances ahead of spin-off
Pharmaphorum
Novartis
Sandoz
spinoffs
generics
biosimilars
Flag link:
Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4
Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4
Fierce Pharma
Novartis
Sandoz
spinoffs
generics
biosimilars
Flag link:
Life After Zimmer Biomet: Why ZimVie Has The "It" Factor
Life After Zimmer Biomet: Why ZimVie Has The "It" Factor
Medical Devices and Diagnostics Industry
ZimVie
Zimmer Biomet
Medtech
dental
Spine
spinoffs
Flag link:
‘You not only know us, you love and trust us:’ How J&J spinoff Kenvue is raising its profile
‘You not only know us, you love and trust us:’ How J&J spinoff Kenvue is raising its profile
Medical Marketing and Media
JNJ
spinoffs
Kenvue
consumer health
Flag link:
As Sandoz prepares to spin off from Novartis, the company sets sights on new crosstown headquarters
As Sandoz prepares to spin off from Novartis, the company sets sights on new crosstown headquarters
Fierce Pharma
Novartis
biosimilars
spinoffs
headquarters
Flag link:
Does Johnson & Johnson's Kenvue Spinoff Make Sense?
Does Johnson & Johnson's Kenvue Spinoff Make Sense?
Motley Fool
JNJ
consumer health
spinoffs
Kenvue
Flag link:
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says
CNBC
JNJ
consumer health
IPOs
Kenvue
spinoffs
Flag link:
Icahn pushes for spinoff of Illumina’s Grail division
Icahn pushes for spinoff of Illumina’s Grail division
BioPharma Dive
Illumina
Grail
Carl Icahn
M&A
spinoffs
Medtech
diagnostics
Flag link:
Bayer's incoming CEO Anderson won't rule out consumer, agriculture spinoffs: report
Bayer's incoming CEO Anderson won't rule out consumer, agriculture spinoffs: report
Fierce Pharma
Bayer
Bill Anderson
Pharma CEOs
spinoffs
consumer health
Flag link:

Pages